EUVIMEDEUVIMED entdecken
Crossref

β-Sitosterol attenuates pulmonary arterial hypertension by activating the Nrf2–GPX4 axis to inhibit ferroptosis in pulmonary vascular cells

Yiming Xie, Jing Li, Juan Liao, Hui Meng, Chuanghong Lu, Zhongyuan Meng, Yan Deng, Jianjun Meng, Feng Huang, Zhiyu Zeng

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.118306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Yiming Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China; Guangxi Key Laboratory of Precision Me…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Ferroptosis, Sitosterols, Phospholipid Hydroperoxide Glutathione Peroxidase. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a progressive vascular disorder in which oxidative stress and ferroptosis are key pathogenic drivers. Although β-sitosterol (BS) shows therapeutic potential in PAH; however, its link to ferroptosis modulation remain poorly elucidated. This study evaluated the anti‑PAH efficacy of BS and its underlying mechanisms, focusing on the Nrf2-GPX4 axis, using a monocrotaline (MCT)‑induced rat model and hypoxia‑induced pulmonary arterial endothelial cells (PAECs) and smooth muscle cells (PASMCs). Inflammation responses, reactive oxygen species (ROS), and ferroptosis-related markers were assessed, along with molecular docking and pharmacological inhibition. In vivo, BS significantly ameliorated pulmonary vascular remodeling, improved right ventricular function, and mitigated oxidative stress by reducing ROS and MDA while restoring GSH levels, while up regulating the ferroptosis-protecive proteins xCT and GPX4. Molecular docking suggested direct interaction between BS and Nrf2. Notably, immunofluorescence revealed Nrf2 localization in both CD31+ endothelial and α‑SMA+ smooth muscle cells, with BS treatment substantially enhancing Nrf2 accumulation in both lineages. In vitro, BS promoted Nrf2 nuclear translocation in hypoxia-induced PAECs and PASMCs, correlating with suppressed oxidative and inflammatory responses and elevated xCT and GPX4 expression. Notably, the anti-oxidative and anti-ferroptotic effects of BS were abolished by the Nrf2 inhibitor ML385. These findings demonstrate that BS attenuates PAH via Nrf2‑GPX4‑driven ferroptosis inhibition in both in PAECs and PASMCs, uncovering a novel therapeutic target and new research directions regarding PAH pathogenesis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2FerroptosisSitosterolsPhospholipid Hydroperoxide Glutathione PeroxidasePulmonary ArteryPulmonary Arterial HypertensionAnimalsRatsRats, Sprague-DawleyMaleEndothelial CellsCells, CulturedMyocytes, Smooth Muscle

Stichwörter der Autor:innen

FerroptosisNrf2Pulmonary arterial hypertensionPulmonary artery endothelial cellsPulmonary artery smooth muscle cellsβ-sitosterol

Substanzen

NF-E2-Related Factor 2Nfe2l2 protein, ratSitosterolsgamma-sitosterolPhospholipid Hydroperoxide Glutathione Peroxidase

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China; Guangxi Key Laboratory of Precision Medicine in Cardio-cerebrovascular Diseases Control and Prevention, Guan…
  • Healthcare Outpatient Clinic, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China; Guangxi Key Laboratory of Precision Medicine in Cardio-cerebrovascular Diseases Control and Prevention, G…
  • Department of Echocardiography of Cardiovascular Disease Institute, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
  • Department of Cardiology, Affiliated Hospital of Youjiang Medical University for Nationalities, No.18 Zhongshan 2nd Road, Youjiang District, Baise City, Guangxi 533000, China.
  • Healthcare Outpatient Clinic, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.

Zitieren

APA

Xie, Y., Li, J., Liao, J., Meng, H., Lu, C., Meng, Z., Deng, Y., Meng, J., Huang, F., & Zeng, Z. (2026). β-Sitosterol attenuates pulmonary arterial hypertension by activating the Nrf2–GPX4 axis to inhibit ferroptosis in pulmonary vascular cells. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118306

Vancouver

Xie Y, Li J, Liao J, Meng H, Lu C, Meng Z, et al. β-Sitosterol attenuates pulmonary arterial hypertension by activating the Nrf2–GPX4 axis to inhibit ferroptosis in pulmonary vascular cells. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118306

BibTeX
@article{Xie2026,
  author = {Xie, Yiming and Li, Jing and Liao, Juan and Meng, Hui and Lu, Chuanghong and Meng, Zhongyuan and Deng, Yan and Meng, Jianjun and Huang, Feng and Zeng, Zhiyu},
  title = {β-Sitosterol attenuates pulmonary arterial hypertension by activating the Nrf2–GPX4 axis to inhibit ferroptosis in pulmonary vascular cells},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.118306}
}
Kostenlos starten →